U.S. Household Products Stock News

Goodyear Tire & Rubber (NasdaqGS:GT) was a plaintiff in a recent U.S. Supreme Court case that limited the federal government's ability to impose tariffs under emergency powers. The ruling affects how future tariffs may be applied to imported goods, a key consideration for companies with global supply chains such as Goodyear. Separately, Goodyear will have a prominent role in the upcoming IROC Heritage Invitational, featuring legendary NASCAR drivers and a revival of the IROC brand. The event...

Calumet (CLMT) closed out FY 2025 with Q4 revenue of US$1,038.6 million and a basic EPS loss of US$0.43, alongside a trailing twelve month revenue base of US$4.1 billion and a TTM EPS loss of US$0.39. Over recent quarters, revenue has ranged from US$993.9 million to US$1,078 million while quarterly EPS has swung between a loss of US$1.87 and a profit of US$3.61, so this latest print keeps the story focused squarely on how efficiently that revenue is being converted into earnings. With the...

MoonLake Immunotherapeutics reported positive topline Phase 2 results for Sonelokimab in axial spondyloarthritis. The company plans to move Sonelokimab into Phase 3 trials, supported by recent regulatory feedback. MoonLake is preparing for a future Biologics License Application and expanding development and manufacturing partnerships. MoonLake Immunotherapeutics, listed as NasdaqCM:MLTX, is drawing fresh attention after the Sonelokimab Phase 2 readout in axial spondyloarthritis and plans...

Ellington Financial (NYSE:EFC) is acquiring a residential mortgage servicer as part of a move toward greater vertical integration. The company is expanding its investment portfolio beyond its existing holdings in mortgage and consumer credit assets. Ellington Financial has issued unsecured notes and completed multiple securitizations as part of a broader capital structure update. Ellington Financial, a specialty finance company listed on the NYSE under the ticker EFC, focuses on...

Millicom International Cellular (NasdaqGS:TIGO) closed FY 2025 with fourth quarter revenue of US$1.7b and basic EPS of US$1.51, alongside net income from ongoing operations of US$252m. The company reported quarterly revenue of US$1.43b in Q4 2024, US$1.37b in Q1 2025, US$1.37b in Q2, US$1.42b in Q3 and US$1.65b in Q4 2025. Over the same period, basic EPS ranged from US$0.20 to US$4.05. This set of results highlights the role of richer margins and a sizeable one off gain in shaping how...

Celsius Holdings (NasdaqCM:CELH) reported record full year revenue in 2025. Results were driven by the acquisitions and integration of Alani Nu and Rockstar Energy. The company further integrated into the PepsiCo system and expanded internationally. Celsius launched a new brand studio and a Fizz Free product line during 2025. Celsius Holdings operates in the energy drink category, a segment that continues to attract strong consumer attention as shoppers look for functional beverages and...

Sharplink (NasdaqCM:SBET) has appointed digital assets specialist Steven Ehrlich as Head of Research and Communications. Ehrlich brings experience from prior roles at Forbes and Unchained, where he focused on digital asset journalism and research. The appointment marks a change in Sharplink’s leadership team aimed at strengthening its research and communication function. For investors, this move sits at the intersection of media, data, and digital assets, an area that continues to attract...

Clover Health Investments FY 2025 Earnings Snapshot Clover Health Investments (CLOV) has wrapped up FY 2025 with Q4 revenue of US$487.7 million and a basic EPS loss of US$0.10, alongside a trailing 12 month revenue figure of about US$1.9 billion and a basic EPS loss of US$0.17 that keeps the company in loss making territory. Over the past few quarters, the company has seen quarterly revenue move from US$462.3 million in Q1 2025 to US$496.7 million in Q3 2025 before ending the year at US$487.7...

Autodesk (ADSK) has wrapped up FY 2026 with Q4 revenue of US$1.96b and basic EPS of US$1.49, alongside trailing twelve month revenue of US$7.21b and EPS of US$5.28, setting a clear reference point for how the business is currently performing. Over recent periods, the company has seen revenue move from US$6.13b on a trailing basis in FY 2025 to US$7.21b in FY 2026, while trailing EPS shifted from US$5.17 to US$5.28. This gives investors a clearer view of how top line scale and per share...

Diebold Nixdorf (NYSE:DBD) has named Jeffrey Sesplankis as its principal accounting officer. Sesplankis succeeds Thomas S. Timko in this key finance and reporting role. Diebold Nixdorf, known for its ATM, payments and retail technology solutions, sits at the intersection of banking infrastructure and physical commerce. For investors, changes in senior finance roles can matter as much as product announcements, because they speak to how the company manages its books, oversees internal...

NovoCure (NasdaqGS:NVCR) received FDA approval for Optune Pax in locally advanced pancreatic cancer and has started commercial launch. The approval extends the company’s Tumor Treating Fields technology beyond its historic focus in glioblastoma into a new oncology market. NovoCure also announced a new CEO and a reorganization of its clinical team alongside the launch. NovoCure now trades around $13.67, with the stock up 20.3% over the past week and 8.7% over the past month, while longer...

Stagwell’s Harris Poll unit has launched Harris QuestRQ, an always-on reputation intelligence platform. The new tool is designed to give businesses real-time tracking of brand reputation and related insights. The launch adds a fresh product to Stagwell’s marketing and communications offering under ticker NasdaqGS:STGW. For investors watching NasdaqGS:STGW, the Harris QuestRQ launch lands at a time when the stock has been volatile, with a 23.4% decline over the past 30 days and a 25.7%...

If you are wondering whether Invesco's current share price really reflects its fundamentals, you are not alone. This article focuses squarely on what you might be paying for and what you are getting. Invesco's stock closed at US$26.26, with returns of 57.2% over 1 year and 68.9% over 3 years, even as the last 7 days, 30 days and year to date show declines of 0.8%, 4.7% and 2.5% respectively. Recent coverage around Invesco has focused on its position in asset management and how investors view...

The Timken Company recently authorized a share repurchase program for up to 10,000,000 shares through February 28, 2031, while also signaling continued interest in mergers and acquisitions, including opportunities linked to humanoid robotics. By pairing a long-duration buyback plan with an active M&A agenda, Timken is emphasizing both capital return and portfolio expansion as key priorities. Next, we’ll examine how Timken’s long-term share repurchase authorization could reshape its existing...

Accelerant Holdings (NYSE:ARX) appointed Cliff Jenks as General Counsel and Corporate Secretary, succeeding founding executive Nancy Hasley, who is retiring. The company also created a new Head of Investor Relations role, naming Ray Iardella to lead engagement with shareholders and the market. These leadership changes focus on legal governance and investor communications, two areas that are central to how the company presents itself to public markets. Accelerant Holdings, trading at around...

Natera (NTRA) just closed out FY 2025 with fourth quarter revenue of US$665.5 million and basic EPS of US$0.34, alongside trailing twelve month revenue of about US$2.3 billion and a TTM basic EPS loss of US$1.52. The company has seen quarterly revenue move from US$476.1 million in Q4 2024 to US$665.5 million in Q4 2025, while quarterly basic EPS shifted from a loss of US$0.41 in Q4 2024 to EPS of US$0.34 in Q4 2025. This sets up a results season where investors are focused squarely on how...

Lamar Advertising recently declared a past quarterly cash dividend of US$1.60 per share, payable on March 31, 2026, and extended its stock and debt repurchase programs, each authorizing up to US$250.00 million through September 30, 2027. These moves highlight management’s focus on returning capital to shareholders while signaling confidence in the company’s balance sheet and cash-generation capacity. Now we’ll examine how the extended stock repurchase authorization influences Lamar’s...

Relay Therapeutics FY 2025 earnings: revenue modest, losses continue as investors focus on growth potential Relay Therapeutics (RLAY) has wrapped up FY 2025 with Q4 revenue of US$7 million, a basic EPS loss of US$0.32, and net income loss of US$54.89 million, keeping the story firmly in loss-making territory as the market weighs its growth profile. The company has seen quarterly revenue move between US$0 million and US$7.68 million over the past year, while basic EPS losses have ranged from...

Central Garden & Pet reported a 6% year over year revenue decline in its latest quarter. The company expanded its share repurchase program, signaling an increased focus on buybacks. Central Garden & Pet also refreshed its board of directors with new appointments. Central Garden & Pet, traded as NasdaqGS:CENT, released results that showed weaker revenue and earnings alongside the slowest revenue growth among its household product peers. The stock last closed at $39.18 and is up 22.1% over...

ON Semiconductor is sharpening its focus on higher margin areas, including silicon carbide products and AI data center power solutions. The company is reallocating capital toward projects it views as higher return and scaling back exposure to weaker end markets such as electric vehicles and smartphones. Management is emphasizing capital discipline and targeted investment as it reshapes the business mix of NasdaqGS:ON. For investors tracking NasdaqGS:ON, this reset comes with the stock...

Vera Therapeutics reported full-year 2025 results showing a net loss of US$299.62 million, while advancing atacicept with positive Phase 3 IgA nephropathy data and securing FDA priority review with a July 7, 2026 PDUFA date. Alongside filing a US$191.89 million Class A common stock shelf registration for an ESOP-related offering, the company highlighted that its cash, equivalents, marketable securities and debt facility availability are expected to fund operations through potential atacicept...

The Honest Company, Inc. recently reported that full-year 2025 sales slipped to US$371.32 million while net loss more than doubled to US$15.69 million, and simultaneously announced a new US$25 million share repurchase program funded by cash on hand and operating cash flows. Alongside this, management issued 2026 guidance calling for an anticipated high-teens percentage decline in reported revenue due to exited categories, while emphasizing 4% to 6% organic growth as the core metric of its...

If you are wondering whether Evercore's current share price fairly reflects its underlying worth, you are not alone. This article is designed to help you size that up clearly. The stock last closed at US$308.84, with returns of 29.2% over 1 year and a 144.5% gain over 3 years, even though the past 7 days and 30 days show declines of 5.9% and 15.0% and the year to date return sits at a 12.1% decline. Recent coverage has focused on Evercore's role as a major independent investment bank in...

If you are wondering whether Vistance Networks at around US$17.57 still offers value after a strong run, this article will help you size up the price against the fundamentals. The stock has pulled back with a 7.4% decline over the last week and a 6.5% decline over the last 30 days, yet it still sits on a 176.7% return over the past year and 125.3% over three years. Recent price moves come as the market continues to react to ongoing news flow around Vistance Networks, including growing...